Sastre-Garriga J - Search Results

1

Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study.

Margoni M, Pagani E, Meani A, Storelli L, Mesaros S, Drulovic J, Barkhof F, Vrenken H, Strijbis E, Gallo A, Bisecco A, Pareto D, Sastre-Garriga J, Ciccarelli O, Yiannakas M, Palace J, Preziosa P, Rocca MA, Filippi M; MAGNIMS Study Group. Margoni M, et al. J Neurol Neurosurg Psychiatry. 2022 Jul;93(7):741-752. doi: 10.1136/jnnp-2022-328908. Epub 2022 May 17. J Neurol Neurosurg Psychiatry. 2022. PMID: 35580993

2

Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis.

Sastre-Garriga J, Reverter JC, Font J, Tintoré M, Espinosa G, Montalban X. Sastre-Garriga J, et al. Ann Neurol. 2001 Mar;49(3):408-11. Ann Neurol. 2001. PMID: 11261519

3

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

Tintoré M, Rovira A, Río J, Nos C, Grivé E, Sastre-Garriga J, Pericot I, Sánchez E, Comabella M, Montalban X. Tintoré M, et al. Neurology. 2003 Jan 14;60(1):27-30. doi: 10.1212/wnl.60.1.27. Neurology. 2003. PMID: 12525713

4

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH. Tiberio M, et al. Neurology. 2005 Mar 22;64(6):1001-7. doi: 10.1212/01.WNL.0000154526.22878.30. Neurology. 2005. PMID: 15781816 Clinical Trial.

5

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

Sastre-Garriga J, Ingle GT, Chard DT, Cercignani M, Ramió-Torrentà L, Miller DH, Thompson AJ. Sastre-Garriga J, et al. Brain. 2005 Jun;128(Pt 6):1454-60. doi: 10.1093/brain/awh498. Epub 2005 Apr 7. Brain. 2005. PMID: 15817511

6

Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, McLean MA, Miller DH, Thompson AJ. Sastre-Garriga J, et al. Arch Neurol. 2005 Apr;62(4):569-73. doi: 10.1001/archneur.62.4.569. Arch Neurol. 2005. PMID: 15824254 Clinical Trial.

7

Is inflammation important in early PPMS? a longitudinal MRI study.

Ingle GT, Sastre-Garriga J, Miller DH, Thompson AJ. Ingle GT, et al. J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1255-8. doi: 10.1136/jnnp.2004.036590. J Neurol Neurosurg Psychiatry. 2005. PMID: 16107362 Free PMC article.

8

Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data.

Sastre-Garriga J, Ingle GT, Rovaris M, Téllez N, Jasperse B, Altmann DR, Benedetti B, Stevenson VL, Cercignani M, Leary SM, Barkhof F, Brochet B, Dousset V, Filippi M, Montalban X, Kalkers NF, Polman CH, Rovira A, Miller DH, Thompson AJ. Sastre-Garriga J, et al. Neurology. 2005 Aug 23;65(4):633-5. doi: 10.1212/01.wnl.0000173061.12776.1f. Neurology. 2005. PMID: 16116134

9

Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis.

Karrenbauer VD, Leoni V, Lim ET, Giovannoni G, Ingle GT, Sastre-Garriga J, Thompson AJ, Rashid W, Davies G, Miller DH, Björkhem I, Masterman T. Karrenbauer VD, et al. Clin Neurol Neurosurg. 2006 Jul;108(5):456-60. doi: 10.1016/j.clineuro.2005.07.010. Epub 2005 Sep 6. Clin Neurol Neurosurg. 2006. PMID: 16144738

10

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.

Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, McLean MA, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH. Tiberio M, et al. J Neurol. 2006 Feb;253(2):224-30. doi: 10.1007/s00415-005-0964-z. Epub 2005 Nov 24. J Neurol. 2006. PMID: 16307201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page